- Investing Ideas
- /
- Global Large Cap High Growth Potential
Global Large Cap High Growth Potential
Results
632
0 new
Large Cap Companies that analysts expect to have high earnings, revenue or cash flow growth in the next 3 years.
632 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
600760 | CN¥49.40 | -2.1% | 16.6% | CN¥136.1b | CN¥53.90 | PE55.3x | E28.9% | 0.8% | Capital Goods | ||
9992 | HK$83.45 | 11.0% | 249.9% | HK$110.7b | HK$80.40 | PE67.5x | E35.4% | 0.4% | Retail | ||
RHM | €619.00 | 7.5% | 118.4% | €26.9b | €674.93 | PE39.2x | E29.0% | 0.9% | Capital Goods | ||
ALNY | US$244.89 | 4.0% | 50.3% | US$31.6b | US$301.21 | PS15.1x | E70.7% | n/a | Pharmaceuticals & Biotech | ||
ONON | US$58.13 | 12.0% | 104.1% | US$18.6b | US$58.64 | PE132.1x | E29.6% | n/a | Consumer Durables | ||
ARES | US$175.52 | 5.0% | 60.7% | US$54.9b | US$174.38 | PE82x | E46.3% | 2.1% | Diversified Financials | ||
SRPT | US$114.23 | 9.3% | 37.8% | US$10.9b | US$189.62 | PE89.5x | E42.6% | n/a | Pharmaceuticals & Biotech | ||
NVDA | US$141.95 | -0.02% | 197.1% | US$3.5t | US$170.44 | PE55.1x | E24.2% | 0.03% | Semiconductors | ||
CGPOWER | ₹730.05 | 5.0% | 70.1% | ₹1.1t | ₹752.40 | PE125.1x | E23.4% | 0.2% | Capital Goods | ||
300308 | CN¥132.28 | -5.9% | 96.2% | CN¥146.1b | CN¥191.56 | PE31.6x | E32.6% | 0.2% | Tech | ||
511243 | ₹1,209.55 | 0.3% | 10.5% | ₹1.0t | ₹1,528.00 | PE26.4x | E21.9% | 0.2% | Diversified Financials | ||
SUZLON | ₹65.22 | 15.0% | 60.6% | ₹890.0b | ₹74.83 | PE92.7x | E39.4% | n/a | Capital Goods | ||
NU | US$13.91 | -1.1% | 69.4% | US$66.9b | US$15.94 | PB8.7x | E29.0% | n/a | Banks | ||
SGEN | US$228.74 | 4.5% | 76.5% | US$43.2b | US$228.91 | PS18.8x | E71.8% | n/a | Pharmaceuticals & Biotech | ||
A196170 | ₩292,000.00 | -33.3% | 294.1% | ₩15.6t | ₩390,000.00 | PS171.4x | E94.1% | n/a | Pharmaceuticals & Biotech | ||
FM | CA$19.28 | 9.5% | 44.9% | CA$16.0b | CA$21.53 | PS2.4x | E68.4% | n/a | Materials | ||
BX | US$199.05 | 9.7% | 86.0% | US$243.2b | US$168.90 | PE68.7x | E27.9% | 1.7% | Diversified Financials | ||
300502 | CN¥118.00 | -7.6% | 177.2% | CN¥83.6b | CN¥151.97 | PE43.9x | E36.7% | 0.1% | Tech | ||
SOLARINDS | ₹10,036.95 | 0.3% | 47.9% | ₹908.2b | ₹11,698.00 | PE89.9x | E27.0% | 0.08% | Materials | ||
ARGX | €582.60 | 7.9% | 28.9% | €35.2b | €578.70 | PS19.2x | E55.4% | n/a | Pharmaceuticals & Biotech | ||
KSPI | US$104.00 | -5.4% | 8.3% | US$19.8b | US$139.13 | PE10.1x | E23.7% | 6.6% | Diversified Financials | ||
600989 | CN¥16.03 | 1.7% | 8.9% | CN¥117.6b | CN¥21.74 | PE18.7x | E38.8% | 1.7% | Materials | ||
SMCI | US$33.15 | 78.4% | 16.0% | US$19.4b | US$40.32 | PE16.1x | E24.3% | n/a | Tech | ||
6669 | NT$2,130.00 | -1.4% | 21.7% | NT$395.8b | NT$2,703.06 | PE20.6x | E20.2% | 2.0% | Tech |